Industry News and Headlines

STAT+: Justice Department Backs AbbVie in Its Bid to Overturn a Colorado Law Guiding a Drug Discount Program

The U.S. Department of Justice filed an amicus brief supporting AbbVie in its effort to overturn a Colorado statute that prohibits pharmaceutical manufacturers from limiting discounts under the federal 340B drug pricing program when hospitals use contract pharmacies. The Colorado law, enacted six years ago, bars drugmakers from placing restrictions on discounts for drugs dispensed through third‑party pharmacies. AbbVie argues the state rule conflicts with federal 340B regulations and infringes on its contractual freedom. The case could set a precedent that reshapes how 340B discounts are applied nationwide.